Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

Recent & Breaking News (TSX:EDT)

Spectral Offering Investors a Deeper Look into Medical Operations

Stockhouse Editorial July 8, 2019

Spectral Announces Voting Results of Annual and Special Meeting

GlobeNewswire June 5, 2019

Spectral Medical Releases Q1 2019 Results

Stockhouse Editorial May 9, 2019

Spectral Announces First Quarter Results

GlobeNewswire May 9, 2019

Untapped Potential in Healthcare Worth Billions

Jonathon Brown May 8, 2019

Spectral Announces Fourth Quarter and Fiscal 2018 Results

GlobeNewswire March 28, 2019

Spectral Expands its Renal Replacement Therapy Development Program to Include the Home Dialysis Market

GlobeNewswire March 20, 2019

Spectral Announces First Orders of Its Proprietary CRRT Machine

GlobeNewswire February 21, 2019

Spectral Announces Approval of Tigris Trial by the US FDA

GlobeNewswire February 19, 2019

Spectral Announces Distribution Agreement for its Proprietary CRRT Machine

GlobeNewswire January 22, 2019

Spectral to Attend the 37th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 19, 2018

Spectral Announces Results of a Face-to-Face meeting with the U.S. FDA

GlobeNewswire December 17, 2018

Spectral Announces Publication of the post hoc analysis of EUPHRATES trial in Intensive Care Medicine

GlobeNewswire November 26, 2018

Spectral Announces Third Quarter Results

GlobeNewswire November 14, 2018

Spectral to enhance the Sales and Marketing team in Canada

GlobeNewswire October 31, 2018

Spectral Announces Presentation at the European Society of Intensive Care Medicine Oct 22nd and Publication of Overall Results of the EUPHRATES trial in JAMA

GlobeNewswire October 18, 2018

Spectral Enters into Technology Transfer Transaction And Provides Update on US FDA Process

GlobeNewswire October 1, 2018

Spectral Announces Second Quarter Results

GlobeNewswire August 14, 2018

Spectral Announces Successful Manufacturing Audit of Toray by the US FDA

GlobeNewswire July 18, 2018

Spectral Announces Voting Results of Annual Meeting

GlobeNewswire June 7, 2018